Trademarkia Logo

Australia

AU$
OREXPANT
Cancelled: Cancelled at the request of IB

Last updated on 9 Jan 2021

Owner Info

Karyopharm Therapeutics Inc.

85 Wells Avenue

Newton MA 02459, UNITED STATES OF AMERICA

Serial Number

1919534 filed on 16 Jan 2018

Correspondent

Nicole Kinsley, Esq. Foley Hoag LLP

155 Seaport Boulevard,

Boston MA 02210,

UNITED STATES OF AMERICA

OREXPANT

Classification Information


Class [005]
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and an Read More

Mark Details


Serial Number

1919534

Registered On

16 Jan 2018

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
9th Jan 2021Status change to Voided
13th Nov 2018IP Right Registration Published
13th Nov 2018International Registration in Australia Protected correspondence sent
13th Nov 2018Status change to Registered/Protected
6th Sept 2018IP Right Acceptance Published
2th Sept 2018Clear Examination report approved
2th Sept 2018User Created Notice correspondence sent
2th Sept 2018Application Accepted correspondence sent
19th Apr 2018IP Right Filed Published
18th Apr 2018Application Status